Xortx therapeutics clarifies halt of trading in canada and timing for commencement of trading on tsx venture exchange

Calgary, alberta, nov. 04, 2021 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (tsxv: xrtx | nasdaq: xrtx), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, wishes to clarify that the company's common shares were halted on both the tsx venture exchange (the “tsxv”) and the canadian securities exchange (the “cse”) to finalize the de-listing procedures required on the cse.  the common shares will be de-listed from the cse at close of market today and the common shares will re-commence trading tomorrow, friday, november 5, on the tsxv under the trading symbol xrtx.
XRTX Ratings Summary
XRTX Quant Ranking